Advocacy at a Glance STEVEN GROSSMAN 12/18/20 Advocacy at a Glance STEVEN GROSSMAN 12/18/20 House-Senate Near Completion of Combo Appropriations/COVID-19 Relief Bill Read More Analysis and Commentary STEVEN GROSSMAN 6/12/20 Analysis and Commentary STEVEN GROSSMAN 6/12/20 "I Believe in FDA Exceptionalism and You Should Too" Read More Advocacy at a Glance STEVEN GROSSMAN 9/6/19 Advocacy at a Glance STEVEN GROSSMAN 9/6/19 Congress Returns September 9/10 to Hectic Fall, Including Funding Bills Read More Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Sometimes There Really Is a Win-Win Read More Advocacy at a Glance STEVEN GROSSMAN 11/21/16 Advocacy at a Glance STEVEN GROSSMAN 11/21/16 Short-Term Continuing Resolution Likely Read More Advocacy at a Glance STEVEN GROSSMAN 6/10/16 Advocacy at a Glance STEVEN GROSSMAN 6/10/16 Speaker Ryan Changes Floor Rules to Expedite Appropriations Bills Read More Analysis and Commentary STEVEN GROSSMAN 1/23/16 Analysis and Commentary STEVEN GROSSMAN 1/23/16 Why Have We Watched "Cures" So Closely? Read More
Advocacy at a Glance STEVEN GROSSMAN 12/18/20 Advocacy at a Glance STEVEN GROSSMAN 12/18/20 House-Senate Near Completion of Combo Appropriations/COVID-19 Relief Bill Read More
Analysis and Commentary STEVEN GROSSMAN 6/12/20 Analysis and Commentary STEVEN GROSSMAN 6/12/20 "I Believe in FDA Exceptionalism and You Should Too" Read More
Advocacy at a Glance STEVEN GROSSMAN 9/6/19 Advocacy at a Glance STEVEN GROSSMAN 9/6/19 Congress Returns September 9/10 to Hectic Fall, Including Funding Bills Read More
Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Sometimes There Really Is a Win-Win Read More
Advocacy at a Glance STEVEN GROSSMAN 11/21/16 Advocacy at a Glance STEVEN GROSSMAN 11/21/16 Short-Term Continuing Resolution Likely Read More
Advocacy at a Glance STEVEN GROSSMAN 6/10/16 Advocacy at a Glance STEVEN GROSSMAN 6/10/16 Speaker Ryan Changes Floor Rules to Expedite Appropriations Bills Read More
Analysis and Commentary STEVEN GROSSMAN 1/23/16 Analysis and Commentary STEVEN GROSSMAN 1/23/16 Why Have We Watched "Cures" So Closely? Read More
